SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-036486
Filing Date
2022-12-23
Accepted
2022-12-23 16:30:16
Documents
14
Period of Report
2022-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52508
2 ex10-1.htm EX-10.1 286068
3 ex10-2.htm EX-10.2 112310
  Complete submission text file 0001493152-22-036486.txt   709209

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE indp-20221222.xsd EX-101.SCH 3039
5 XBRL LABEL FILE indp-20221222_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE indp-20221222_pre.xml EX-101.PRE 22599
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3498
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 221485682
SIC: 2834 Pharmaceutical Preparations